Xenon Pharmaceuticals Inc... (XENE)
NASDAQ: XENE
· Real-Time Price · USD
38.23
0.27 (0.71%)
At close: Aug 15, 2025, 3:59 PM
38.23
0.00%
After-hours: Aug 15, 2025, 04:42 PM EDT
Xenon Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 116.66M | 142.71M | 87.62M | 136.73M | 58.9M | 148.64M | 99.57M | 64.55M | 69.51M | 57.24M | 103.49M | 369.99M | 116.54M | 175.69M | 87.81M | 82.93M | 87.98M |
Short-Term Investments | 432.97M | 484.19M | 566.39M | 584.8M | 640.71M | 489.44M | 427.1M | 475.05M | 457.53M | 534.85M | 534.7M | 418.25M | 421.4M | 376.09M | 161.82M | 177.59M | 186.72M |
Long-Term Investments | 141.5M | 127.5M | 149.32M | 129.06M | 185.84M | 292.79M | 112.41M | 112.59M | 160.26M | 128.68M | 113.99M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 8.05M | 7.5M | 7.47M | 7.42M | 7.31M | 7.4M | 27.68M | 27.69M | 7.96M | 7.75M | 113.99M | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | 8.65M | 1.47M | 938K | 853K | 833K | 874K | 805K | 2.12M | 2.22M | 986K | 2.48M | 2.52M | 2.92M | 2.77M | 3.23M | 2.92M | 5.06M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | -805K | -2.12M | n/a | -986K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 7.26M | 6.89M | 4.69M | 5.7M | 6.77M | 6.01M | 3.53M | 2.89M | 4.09M | 7.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 565.54M | 635.26M | 659.64M | 728.09M | 707.2M | 644.96M | 531.01M | 544.62M | 533.35M | 600.3M | 649.18M | 794.8M | 545.62M | 559.02M | 256.31M | 266.75M | 283.26M |
Property-Plant & Equipment | 17.31M | 18.22M | 18.42M | 18.71M | 18.28M | 18.85M | 19.73M | 19.36M | 18.07M | 16.91M | 12.13M | 12.27M | 12.24M | 12.52M | 7.23M | 7.41M | 6.9M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | -20.33M | -19.81M | n/a | n/a | -113.99M | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 177.74M | 162.88M | 176.26M | 155.92M | 211.82M | 319.84M | 140.09M | 140.28M | 186.52M | 153.85M | 126.64M | 12.58M | 12.44M | 12.99M | 8.04M | 7.96M | 7.41M |
Total Assets | 743.28M | 798.14M | 835.9M | 884.01M | 919.02M | 964.8M | 671.09M | 684.9M | 719.87M | 754.15M | 775.81M | 807.38M | 558.06M | 572.01M | 264.35M | 274.71M | 290.67M |
Account Payables | 6.88M | 5.07M | 5.42M | 9.5M | 6.43M | 8.6M | 6.1M | 12.03M | 11.41M | 8.49M | 3.08M | 3.18M | 1.66M | 3.82M | 3.08M | 3.28M | 2.13M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | -6.1M | 13.69M | n/a | n/a | n/a | -7.85M | -8.22M | n/a | 2.2M | 3.02M | 3.64M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 5.05M | 9.93M | 8.94M | 14.24M | 10.65M | 9.95M | 11.55M | 9.98M | 7.22M | 7.9M | 8.23M | 7.24M | 4.22M | 3.95M | 3.5M | 5.46M | 4.13M |
Total Current Liabilities | 32.03M | 35.59M | 29.7M | 31.29M | 22.22M | 27.27M | 24.74M | 28.16M | 22.49M | 22.7M | 15.54M | 13.74M | 7.98M | 14.32M | 12.86M | 14.98M | 11.49M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | 19.91M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 7.29M | 7.65M | 28.31M | 8.68M | 9.1M | 9.6M | 9.76M | 10.28M | 10.43M | 9.95M | 7.16M | 7.85M | 8.22M | 7.65M | 2.56M | 2.75M | 2.9M |
Total Liabilities | 39.32M | 43.24M | 38.09M | 39.96M | 31.32M | 36.88M | 34.5M | 38.44M | 32.92M | 32.65M | 22.69M | 21.59M | 16.21M | 21.97M | 15.41M | 17.73M | 14.39M |
Total Debt | 8.68M | 9.02M | 9.79M | 10.03M | 10.43M | 10.9M | 11M | 11.51M | 11.63M | 10.44M | 7.16M | 7.85M | 8.22M | 8.26M | 3.24M | 3.5M | 3.17M |
Common Stock | 1.46B | 1.46B | 1.44B | 1.44B | 1.44B | 1.44B | 1.12B | 1.08B | 1.07B | 1.07B | 1.06B | 1.06B | 800.31M | 783.17M | 504.39M | 499.35M | 498.33M |
Retained Earnings | -964.52M | -899.47M | -833.78M | -771M | -713.07M | -665.14M | -620.4M | -571.93M | -524.47M | -482.75M | -445.35M | -408.2M | -377.04M | -357.37M | -331.81M | -316.37M | -294.26M |
Comprehensive Income | -836K | -1.61M | 1.34M | -2.21M | -1.77M | -77K | -2.95M | -3.3M | -1.82M | -3M | -2.96M | -990K | -990K | -990K | -990K | -990K | -990K |
Shareholders Equity | 703.96M | 754.9M | 797.81M | 844.05M | 887.7M | 927.92M | 636.59M | 646.46M | 686.94M | 721.5M | 753.12M | 785.79M | 541.85M | 550.03M | 248.94M | 256.98M | 276.28M |
Total Investments | 574.47M | 611.69M | 715.71M | 713.86M | 826.54M | 782.23M | 427.1M | 475.05M | 457.53M | 663.53M | 648.68M | 418.25M | 421.4M | 376.09M | 161.82M | 177.59M | 186.72M |